Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
Sponsor: University of Miami
A observational or N/A phase clinical study on Prostate Cancer, this trial is actively recruiting participants. The trial is conducted by University of Miami and has accumulated 7 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Apr 28, 2026 — Present [daily]
Recruiting
Phase: NA → None
-
May 2025 — Apr 2026 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — May 2025 [monthly]
Not Yet Recruiting NA
-
Feb 2025 — Mar 2025 [monthly]
Not Yet Recruiting NA
-
Oct 2024 — Feb 2025 [monthly]
Not Yet Recruiting NA
▶ Show 2 earlier versions
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
The study aims to investigate whether following a controlled Mediterranean-style diet prior to robotic-assisted radical prostatectomy surgery in patients diagnosed with prostate cancer affects fasting insulin levels and other values that can be measured in blood and tissue samples from surgery.
Contact Information
- University of Miami
For direct contact, visit the study record on ClinicalTrials.gov .